| [1] |
于晗. 比索洛尔治疗慢性心衰的临床效果及对抗心脏 β1和M2受体自身抗体和心功能的影响分析[J].医学理论与实践,2018,31(24):3669-3670.
|
| [2] |
李梅琼. 比索洛尔对慢性心力衰竭治疗的临床效果分析[J].中国医药指南,2018,16(19):156-157.
|
| [3] |
段萍. 比索洛尔对慢性心力衰竭治疗的临床效果评价[J].中外医疗,2018,37(10):114-116.
|
| [4] |
白执. 比索洛尔治疗慢性心力衰竭的临床疗效及其对患者神经内分泌因子水平的影响研究[J].当代医学,2018,24(8):68-70.
|
| [5] |
Shao-Yun Liu,Qian Li.Effect of bisoprolol in combined with trimetazidine on the cardiac function rehabilitation in patients with chronic heart failure[J].海南医科大学学报(英文版),2017,23(17):21-24.
|
| [6] |
Zhi-Hua Zhao.Effect of trimetazidine combined with bisoprolol on the cardiac function, ventricular remodeling and neuroendocrine factors in patients with chronic heart failure[J].海南医科大学学报(英文版),2017,23(9):25-29.
|
| [7] |
Kakehi K,Iwanaga Y,Watanabe H, etal.Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure[J].Cardiovasc Pharmacol Ther,2019,24(4):387-396.
|
| [8] |
Toyoda, Shigeru,Haruyama, et al.Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure[J].Int Cardiol,2017,22(6):71-76.
|
| [9] |
Cvan Trobec K,Grabnar I,Kerec Kos M, et al.Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study[J].Eur Clin Pharmacol,2016,72(7):813-822.
|
| [10] |
Chang, Yu-Sheng,Lee, et al.Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease[J].Medicine.,2016,95(5):1934.
|
| [11] |
Chang, Yu-Sheng,Lee, et al.Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease[J].Medicine.,2016,95(5):1746.
|
| [12] |
Momomura, S I,Saito Y,Yasummura Y, et al.Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure[J].Circulation journal,2018,82(1):141.
|
